期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?
1
作者 Yeo Jeong So sophia frentzas Eva Segelov 《Hepatobiliary Surgery and Nutrition》 SCIE 2019年第5期546-548,共3页
Hepatocellular carcinoma(HCC)is the sixth most commonincident and the fourth most common cause of cancer deathworldwide.It is strongly associated with chronic HepatitisB and C infection and excess alcohol intake(1),ma... Hepatocellular carcinoma(HCC)is the sixth most commonincident and the fourth most common cause of cancer deathworldwide.It is strongly associated with chronic HepatitisB and C infection and excess alcohol intake(1),makingtreatment of patients with HCC complicated,with the almostuniform presence of concurrent cirrhosis and varying degreesof liver failure,which often fluctuates over time. 展开更多
关键词 PATIENTS INTAKE DEATH
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部